Catechol-O-methyltransferase: Characteristics, polymorphisms and role in breast cancer

Drug Discovery Today: Disease Mechanisms

Volumn 9, Issue 1-2, 2012, Pages

  Yager, James D ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE; VALINE;

BREAST CANCER; DNA DAMAGE; GENE EXPRESSION; PROTEIN METHYLATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE;

EID: 84875225571     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2012.10.002     Document Type: Review

References (44)

1. J. Axelrod, and R. Tomchick Enzymatic O-methylation of epinephrine and other catechols J. Biol. Chem. 233 1958 702 705
2. P.T. Mannisto, and S. Kaakkola Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors Pharmacol. Rev. 51 1999 593 628
3. K. Lundstrom Cloning, expression and structure of catechol-O- methyltransferase Biochim. Biophys. Acta 1251 1995 1 10
4. B.T. Zhu Catechol-O-methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis Curr. Drug Metab. 3 2002 321 349
5. I. Ulmanen Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells Eur. J. Biochem. 243 1997 452 459
6. C. Tilgmann Expression of recombinant soluble and membrane-bound catechol O-methyltransferase in eukaryotic cells and identification of the respective enzymes in rat brain Eur. J. Biochem. 207 1992 813 821
7. J. Weisz Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells Am. J. Pathol. 156 2000 1841 1848
8. J.G. Liehr Carcinogenicity of catechol estrogens in Syrian hamsters J. Steroid Biochem. 24 1986 353 356
9. R.R. Newbold, and J.G. Liehr Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res. 60 2000 235 237
10. N. Schutze Catecholestrogens are MCF-7 cell estrogen receptor agonists J. Steroid Biochem. Mol. Biol. 46 1993 781 789
11. M.L. Lottering Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells Cancer Res. 52 1992 5926 5932
12. C.H. Van Aswegen Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers J. Steroid Biochem. 32 1989 485 492
13. E.L. Cavalieri, and E.G. Rogan Unbalanced metabolism of endogenus estrogens in the etiology and prevention of human cancer J. Steroid Biochem. Mol. Biol. 123 2011 169 180
14. J.A. Lavigne The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells Cancer Res. 61 2001 7488 7494
15. M. Zahid Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation Free Radic. Biol. Med. 43 2007 1534 1540
16. F. Barchiesi Candidate genes and mechanisms for 2-methoxyestradiol- mediated vasoprotection Hypertension 56 2010 964 972
17. R.K. Dubey 2-Methoxyestradiol: a potential treatment for multiple proliferative disorders Endocrinology 148 2007 4125 4127
18. N. Klauber Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol Cancer Res. 57 1997 81 86
19. T. Fotsis The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth Nature 368 1994 237 239
20. P.D. Scanlon Catechol-O-methyltransferase: thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity Science 203 1979 63 65
21. R.M. Weinshilboum, and F.A. Raymond Inheritance of low erythrocyte catechol-O-methyltransferase activity in man Am. J. Hum. Genet. 29 1977 125 135
22. H.M. Lachman Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders Pharmacogenetics 6 1996 243 250
23. N.J. Cotton Oxidative inhibition of human soluble catechol-O- methyltransferase J. Biol. Chem. 279 2004 23710 23718
24. J. Vidgren Crystal structure of catechol O-methyltransferase Nature 368 1994 354 358
25. J.E. Goodman Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation Pharmacogenetics 12 2002 517 528
26. A.J. Shield Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes Mol. Psychiatry 9 2004 151 160
27. S. Saito Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population J. Hum. Genet. 46 2001 529 537
28. Y. Ji Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms Cancer Res. 68 2008 5997 6005
29. A.E. Doyle Cancer Lett. 214 2004 189 195
30. A.E. Doyle, and J.D. Yager Catechol-O-methyltransferase: effects of the val108met polymorphism on protein turnover in human cells Biochim. Biophys. Acta 1780 2008 27 33
31. A.G. Nackley Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure Science 314 2006 1930 1933
32. T. Xie Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription Mol. Pharmacol. 56 1999 31 38
33. J.A. Lavigne An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer Cancer Res. 57 1997 5493 5497
34. D.S. Yim Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer Pharmacogenetics 11 2001 279 286
35. C.S. Huang Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility Cancer Res. 59 1999 4870 4875
36. P.A. Thompson Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk Cancer Res. 58 1998 2107 2110
37. R.C. Millikan Catechol-O-methyltransferase and breast cancer risk Carcinogenesis 19 1998 1943 1947
38. H. Ding COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case-control studies Breast Cancer Res. Treat. 123 2010 265 270
39. B. Xi Catechol-O-methyltransferase Val158Met polymorphism in breast cancer risk Breast Cancer Res. Treat. 126 2011 839 840 (author reply 841)
40. C. Mao Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls Breast Cancer Res. Treat. 121 2010 719 725
41. X.F. He Association between the COMT Val158Met polymorphism and breast cancer risk: a meta-analysis of 30,199 cases and 38,922 controls Mol. Biol. Rep. 39 2012 6811 6823
42. J.Z. Cerne Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer J. Gynecol. Oncol. 22 2011 110 119
43. S.C. Fleck Catechol metabolites of zeranol and 17beta-estradiol: a comparative in vitro study on the induction of oxidative DNA damage and methylation by catechol-O-methyltransferase Toxicol. Lett. 210 2012 9 14
44. L. Diatchenko Genetic basis for individual variations in pain perception and the development of a chronic pain condition Hum. Mol. Genet. 14 2005 135 143